Package Leaflet: Information for the User
Lasdul 30 mg hard gastro-resistant capsules EFG
Lasdul 60 mg hard gastro-resistant capsules EFG
Duloxetine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Lasdul contains the active substance duloxetine. Duloxetine increases the levels of serotonin and noradrenaline in the nervous system.
Duloxetine is used in adults to treat:
Duloxetine starts to work in most people with depression or anxiety within 2 weeks of starting treatment, but it may take between 2 and 4 weeks before you start to feel better. Tell your doctor if you do not feel better after this time. Your doctor may continue to give you duloxetine when you are feeling better to prevent your depression or anxiety from returning.
In people with diabetic neuropathic pain, it may take some weeks before you feel better. Consult your doctor if you do not feel better after 2 months.
Consult your doctor if you have high blood pressure or heart disease. Your doctor will tell you if you can take duloxetine.
Duloxetine may not be suitable for you due to the following reasons. Consult your doctor before you start taking this medicine:
Duloxetine may cause a feeling of restlessness or an inability to sit or stand still. If this happens, you should tell your doctor.
Some medicines of the same class as duloxetine (called SSRIs and SNRIs) may cause sexual dysfunction (see section 4). In some cases, these symptoms persist after stopping treatment.
Thoughts of suicide and worsening of your depression or anxiety disorder
If you are depressed and/or have anxiety disorders, you may sometimes have thoughts of harming or killing yourself. These thoughts may be increased when you first start taking antidepressants, since these medicines all take time to work, usually about 2 weeks, but sometimes longer.
You are more likely to have these thoughts if:
It may be helpful for a close relative or friend to read this leaflet. You can ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behavior.
Duloxetine is not normally used in children and adolescents under 18 years. In addition, you should know that patients under 18 have an increased risk of side effects such as suicide attempt, suicidal thoughts, and hostility (predominantly aggression, oppositional behavior, and anger) when they take this class of medicines. Despite this, your doctor may prescribe duloxetine to patients under 18 because they decide that it can be beneficial for the patient. If your doctor has prescribed duloxetine to a patient under 18 and you want to discuss it, please go back to your doctor. You must tell your doctor if any of the above symptoms occur or worsen in patients under 18 taking duloxetine. Also, in this age group, the long-term effects of duloxetine on growth, maturation, and cognitive and behavioral development have not yet been demonstrated.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
The main component of this medicine, duloxetine, is used in other medicines for other treatments:
You should avoid taking more than one of these medicines at the same time. Check with your doctor if you are already taking other medicines that contain duloxetine.
Your doctor will decide if you can take duloxetine with other medicines. Do not start or stop taking any medicines, including those obtained without a prescription, without talking to your doctor first.
You should also tell your doctor if you are taking any of the following medicines:
Monoamine oxidase inhibitors (MAOIs):you should not take duloxetine if you are taking, or have taken, another antidepressant medicine called a monoamine oxidase inhibitor (MAOI) in the last 14 days. Examples of MAOIs include moclobemide (an antidepressant) and linezolid (an antibiotic). Taking an MAOI with many prescription medicines, including duloxetine, can cause serious side effects, even life-threatening ones. You should wait at least 14 days after stopping an MAOI before taking duloxetine. Similarly, you should wait at least 5 days after stopping duloxetine before starting an MAOI.
Medicines that cause drowsiness:these include medicines prescribed by your doctor, such as benzodiazepines, strong painkillers, antipsychotics, phenobarbital, and antihistamines.
Medicines that increase serotonin levels:triptans, tramadol, tryptophan, selective serotonin reuptake inhibitors (SSRIs, such as paroxetine and fluoxetine), serotonin-norepinephrine reuptake inhibitors (SNRIs, such as venlafaxine), tricyclic antidepressants (such as clomipramine and amitriptyline), pethidine, St. John's Wort, and MAOIs (such as moclobemide and linezolid). These medicines increase the risk of side effects; if you notice any unusual symptoms when taking any of these medicines with duloxetine, you should tell your doctor.
Oral anticoagulants or antiplatelet agents:medicines that thin the blood or prevent blood clots. These medicines may increase the risk of bleeding.
Duloxetine can be taken with or without food. You should be careful if you drink alcohol while being treated with duloxetine.
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
While taking duloxetine, you may feel drowsy or dizzy. Do not drive or use tools or machines until you know how duloxetine affects you.
Lasdul contains sucrose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Lasdul contains sodium
This medicine contains less than 23 mg of sodium (1mmol) per capsule; this is essentially "sodium-free".
Follow exactly the instructions given to you by your doctor or pharmacist. If you are not sure, consult your doctor or pharmacist again.
Duloxetine should be taken orally. You should swallow the capsule whole with water.
For depression and diabetic neuropathic pain:
The recommended dose of duloxetine is 60 mg once a day, but your doctor will prescribe the dose that is best for you.
For generalized anxiety disorder:
The usual starting dose of duloxetine is 30 mg once a day, after which most patients will receive 60 mg once a day, but your doctor will prescribe the dose that is best for you. The dose may be adjusted up to 120 mg a day, depending on your response to duloxetine.
To help you remember to take duloxetine, you may find it helpful to take it at the same times each day.
Discuss with your doctor how long you should take duloxetine. Do not stop taking duloxetine, or change your dose, without talking to your doctor. It is important to treat your condition effectively to help you improve. If you do not treat your condition, it may not get better and may become more serious and more difficult to treat.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 91.562.04.20, indicating the medicine and the amount taken
Symptoms produced by an overdose include drowsiness, coma, serotonin syndrome (a rare reaction that can cause intense happiness, drowsiness, clumsiness, restlessness, feeling drunk, fever, sweating, or muscle stiffness), seizures, vomiting, and rapid heartbeat.
If you forget to take a dose, take it as soon as you remember. However, if it is time for your next dose, skip the missed dose and take a single dose as usual. Do not take a double dose to make up for a missed dose. Do not take more duloxetine than prescribed for you in a day.
Do not stop taking your capsules without the advice of your doctor, even if you feel better. If your doctor thinks you do not need to take duloxetine anymore, they will tell you how to reduce your dose over at least 2 weeks before stopping treatment.
Some patients who have stopped taking duloxetine have experienced symptoms such as:
These symptoms are usually not serious and disappear within a few days, but if you have symptoms that are troublesome, ask your doctor for advice.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
These effects are usually mild to moderate and often disappear within a few weeks.
Children and adolescents under 18 years of age with depression treated with this medicine had a decrease in weight when they first started taking this medicine. After 6 months of treatment, their weight increased to levels similar to those of other children and adolescents of the same age and sex.
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report it directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Lasdul 30 mg hard gastro-resistant capsules EFG:
PVC-PVDC/Alu blister: Do not store at a temperature above 30°C. Keep in the original packaging to protect it from light.
Lasdul 60 mg hard gastro-resistant capsules EFG:
PVC-PVDC/Alu blister: Do not store at a temperature above 30°C.
Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medications you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Lasdul is a hard gastro-resistant capsule. Each Lasdul capsule contains duloxetine hydrochloride pellets with a coating to protect them from stomach acid.
Lasdul 30 mg are printed capsules (cap E/body 127), with a blue opaque cap and a white opaque body, approximately 15 mm in length.
Lasdul 60 mg are printed capsules (cap E/body 129), with a blue opaque cap and a green opaque body, approximately 19 mm in length.
Lasdul 30 mg is available in blisters of 7 and 28 capsules.
Lasdul 60 mg is available in blisters of 28 and 56 capsules.
Only some pack sizes may be marketed.
Marketing authorization holder:
Towa Pharmaceutical Europe, S.L.
C/ de Sant Martí 75-97
08107 Martorelles (Barcelona) Spain
Manufacturer:
Towa Pharmaceutical Europe, S.L.
C/ de Sant Martí 75-97
08107 Martorelles (Barcelona) Spain
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/